U.S. Markets open in 10 hrs, 42 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 7.39 09:30 AM EST | |
|---|---|---|
| Day High | 7.75 03:40 PM EST |
|
| Range | 0.36 |
| Volume | 859,343 | |
|---|---|---|
| 30-Day Avg Vol | 1.24 M |
|
| Difference | -31.20% |
| Market Cap | 596.30 M | |
|---|---|---|
| Mkt Cap Chg | 19.36 M |
| Shares Out | 77.44 M | |
|---|---|---|
| % Shrs Traded | 1.11% | |
| 1yr EPS Est | 0.663 |
| 52-Wk Low | 3.79 | |
|---|---|---|
| 52-Wk High | 14.55 |
|
| Range | 10.76 |
| Prev Close | 7.45 11/19/09 | |
|---|---|---|
| Today's Open | 7.39 | |
| Change | -0.81% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.67 M |
| Revenue (LFY) | 232.30 M | |
|---|---|---|
| Earnings (LFY) | 67.62 M | |
| Earnings (MRQ) | 20.07 M | |
| Next Earn Est | 0.214 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | -0.31 | |
| 1yr EPS Growth | 295.00% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 11.00 | |
| PEG Ratio | 0.65 | |
| Return on Equity | 9.61 | |
| Beta | 2.01 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ViroPharma didn't want to wait until its drugs were approved to start making money, so instead it bought an approved one. The development-stage firm discovers drugs to combat RNA viruses, a category that ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.214 2/22/10 | — — |
—
—
|
| Last Quarter | 0.259 9/30/09 | 0.24 9/30/09 |
-0.019
Missed
|
| 2 Quarters Ago | 0.182 6/30/09 | 0.20 6/30/09 |
0.018
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 80.55 M | 232.31 M |
| Gross Profit | 63.58 M | 212.62 M |
| Operating Income | 32.42 M | 80.92 M |
| Net Income | 20.07 M | 67.62 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts